Triple-negative Breast Cancer Cells (IMAGE)

University of Maryland Medical Center

Triple-negative Breast Cancer Cells

Caption

Triple-negative breast cancer is an often-aggressive type of breast cancer that is more common among African-Americans and young women and is very difficult to treat. A new national clinical trial, led by a University of Maryland Greenebaum Cancer Center researcher, will evaluate a novel approach to treat this type of cancer. The NCI-funded study will help researchers determine if an experimental drug, entinostat, can reprogram tumor cells to make them sensitive to hormone therapy with drugs such as aromatase inhibitors

Credit

University of Maryland Greenebaum Cancer Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.